This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Gordon Oliver Potts: Innovator in Pharmaceutical Science
Introduction
Gordon Oliver Potts is a notable inventor based in North Chatham, NY (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of agents that influence reproductive health.
Latest Patents
Potts holds a patent for the "Combined use of an antigestagen and a progesterone synthesis inhibitor." This innovative pharmaceutical agent combines a progesterone synthesis inhibitor, such as trilostane or epostane, with an antigestagen. It is designed for various applications, including inducing delivery at term in humans and animals, terminating normal or pathological pregnancies, and treating hormone-dependent tumors, endometriosis, or dysmenorrhea. He has 1 patent to his name.
Career Highlights
Throughout his career, Potts has worked with Schering Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has focused on advancing medical treatments that address critical health issues.
Collaborations
Potts has collaborated with notable colleagues, including Walter Elger and Sybille Beier, contributing to the advancement of pharmaceutical innovations.
Conclusion
Gordon Oliver Potts is a distinguished inventor whose work in pharmaceutical science has the potential to impact reproductive health significantly. His innovative approaches continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile